The Q3 results fell somewhat short of the street’s expectations, although both the segments saw healthy growth. Meanwhile, the management narrowed its full-year guidance to which the markets expressed their disappointment. Nonetheless, Alcon’s medium-to-long term prospects remain promising, on the back of its dominant position in both segments, material unmet eye care needs across the globe and the ongoing profitability improvements.
15 Nov 2023
Healthy Q3; markets disappointed with the narrowed guidance
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Healthy Q3; markets disappointed with the narrowed guidance
The Q3 results fell somewhat short of the street’s expectations, although both the segments saw healthy growth. Meanwhile, the management narrowed its full-year guidance to which the markets expressed their disappointment. Nonetheless, Alcon’s medium-to-long term prospects remain promising, on the back of its dominant position in both segments, material unmet eye care needs across the globe and the ongoing profitability improvements.